D-0095-2023 Class II Ongoing
FDA drug recall D-0095-2023 was initiated by Eugia US LLC on Dec 28, 2022 and is designated Class II. Reason for recall: Presence of Particulate Matter: Customer complaint of dark particles found inside the vial The recall status is ongoing. Affected quantity: 45,250 vials.
Recall details
- Product Type
- Drugs
- Report Date
- Jan 11, 2023
- Initiation Date
- Dec 28, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 45,250 vials
Product description
Acyclovir Sodium Injection 1,000 mg per 20 mL* (50 mg/mL); Single Dose 20mL Vial, Rx only, Distributed by: AuroMedics Pharma LLC, 279 Princeton-Hightstown Rd, E. Windsor, NJ 08520; Made in India. NDC 55150-155-20
Reason for recall
Presence of Particulate Matter: Customer complaint of dark particles found inside the vial
Distribution pattern
Nationwide in the USA
Code information
Lot # AC22004, Expiry: 08/2023
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0095-2023
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026